Psykey, Inc. (CEOS)

Market Cap	1.41M -47.1%
Revenue (ttm)	n/a
Net Income	-5.01M
EPS	-0.41
Shares Out	313.08M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0060
Previous Close	0.0045
Day's Range	0.0060 - 0.0060
52-Week Range	0.0006 - 0.0090
Beta	0.29
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Psykey

Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2002
• Employees: 6
• Stock Exchange: OTCMKTS
• Ticker Symbol: CEOS

Financial Performance

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 2, 2026

Data Sources Report a data error